Home Options MRVLReports

MRVL

Marvell Technology, Inc.Close $279.04EOD only

Max Pain

$300.00

Next expiry Jun 26, 2026

Expected Move

±$24.95

8.9% from close

Price Gap

+20.96

Distance to max pain

IV Rank

Middle-high premium

P/C OI

1.13

Slightly put-heavy

Consensus

7.5/10

Bullish tilt

Published snapshot: Jun 23, 2026 close

End-of-day snapshot

This page reflects MRVL options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot

Jun 23, 2026 close

MRVL Flow Report

Analysis based on market close June 24, 2026

Directional Theta Gang Flow Earnings Consensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

Flow Verdict

Confidence:

7.5 / 10

base 5; +2 GEX/flow strongly aligned; +1 GEX positive (pinning); -1 spot 6.2% from MP; +0.5 VIX 19

Watch next session: Watch $270 calls, $260 support

Flow Summary

Net premium: +$143.8M bullish

P/C volume ratio: 0.69

P/C OI ratio: 1.14

Net call $143.8M, p/c vol ratio 0.69. Unusual call prints at $270-277.5. Spot below MP but gamma bullish. Low-strike puts as hedges.

Notable Prints

MRVL 2026-11-20 $410.00 Call

Vol: 1,966

OI: 121

Vol/OI: 16.2x

IV: 95.7%

Notional: ~$5.9M

Intent: Bullish speculation on large upside

Dual read: Could be short call sale if IV high

Read-through: Aggressive long call bet

MRVL 2026-07-02 $145.00 Put

Vol: 1,333

OI: 215

Vol/OI: 6.2x

IV: 177.7%

Notional: ~$28K

Intent: Protective hedge against drop

Dual read: Speculative cheap put or part of collar

Read-through: Downside protection with low cost

MRVL 2026-06-26 $270.00 Call

Vol: 2,670

OI: 508

Vol/OI: 5.3x

IV: 104.0%

Notional: ~$3.7M

Intent: Short-term bullish momentum

Dual read: Gamma squeeze or closing of short positions

Read-through: Buying pressure near expiry

MRVL 2026-06-26 $152.50 Put

Vol: 1,377

OI: 279

Vol/OI: 4.9x

IV: 266.4%

Notional: ~$14K

Intent: Unclear flow intent

Read-through: Needs contextual interpretation.

MRVL 2026-06-26 $272.50 Call

Vol: 1,035

OI: 215

Vol/OI: 4.8x

IV: 102.1%

Notional: ~$1.3M

Intent: Unclear flow intent

Read-through: Needs contextual interpretation.

Institutional Positioning

Call additions: Unusual call buying: Nov 410C (vol/OI 16.2), Jun 270C, 272.5C, Dec 290C. Net premium +$144M, put/call vol ratio 0.69.

Put additions: Minor put buying: Jun 152.5P (vol/OI 4.9), Jul 145P, 155P, but negligible vs calls.

GEX/DEX consistency: GEX +$5.8M, DEX +51.1M shares, both positive. Bullish flow consistent with gamma pinning regime.

OI clusters: Largest OI: Nov 410C, Jun 270C, Jul 155P. OI ratio 1.14 puts bias but volume call-dominant.

Hedging evidence: No meaningful put OI within 30% below spot; limited hedging.

Max pain context: Spot below max pain; gamma pinning regime suggests upward drift toward MP.

Signal vs Noise

~Signal: strong call volume vs put volume, net premium positive, unusual prints with high vol/OI ratios.

~Signal: positive GEX/DEX alignment with bullish flow.

~Noise: far OTM put buying (145P, 155P) is likely hedging or noise.

~Noise: high VIX 18.6 increases vol but not directional.

Key Conclusions

🟢Bullish flow with concentrated call buying at upside strikes; gamma pinning supports upside.

⚠️Spot 6.2% below MP may attract pinning; but VIX 19 and high vol add risk.

📊DEX +51.1M shares provides long delta support; call additions suggest institutional upside positioning.

How to Use These Reports

This flow reflects the market close on June 24, 2026.

What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.